Latent Tuberculosis Infection (LTBI) Guidance for the Prevention of Tuberculosis (TB) in California
Links labeled “CDPH LINK” in red, will take you to the CDPH website where they can be downloaded individually. Please note that these pieces have the same content as the information provided in this guideline.
- California Adult Tuberculosis Risk Assessment and User Guide (February 2024 version) (PDF)
- California Pediatric Tuberculosis Risk Assessment and User Guide (February 2024 version) (PDF)
Selecting a Test for Latent TB Infection (LTBI) (June 2019)
Evaluating Patients with a Positive TB Test
Choice of Treatment for Latent TB Infection (LTBI)
12 dose Isoniazid (INH) + Rifapentine Regimen for Latent TB Infection Treatment (September 2018) (CDPH LINK)
Rifampin for Latent TB Infection Treatment (September 2018) (CDPH LINK)
Isoniazid (INH) for Latent TB Infection Treatment (September 2018) (CDPH LINK)